+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

AI Medical Imaging Software for Pneumonia Market by Modality (Ct Scan, Mri, Ultrasound), End User (Clinics, Diagnostic Imaging Centers, Hospitals), Integration, Deployment, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6126999
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pneumonia remains a leading cause of morbidity and mortality worldwide, posing persistent diagnostic challenges across clinical settings. The advent of artificial intelligence in medical imaging has ushered in a new era of precision and speed in detecting pulmonary infections. By leveraging deep learning models trained on diverse imaging modalities, healthcare providers can now achieve earlier and more accurate diagnosis, reducing the risk of complications and improving patient outcomes.

This report explores the intersection of sophisticated algorithms and high-resolution diagnostic tools, charting how AI software integrates seamlessly into radiology workflows. It delves into the technology’s ability to enhance the sensitivity of chest X rays, optimize CT scan interpretations, and support decision-making processes for triage and monitoring. The introduction sets the stage for a comprehensive examination of market forces, regulatory influences, and innovation trajectories shaping the evolution of AI-driven pneumonia imaging solutions.

Mapping the New Frontier in Pneumonia Imaging AI Driven by Data Integration, Deep Learning Algorithms, and Cross Platform Interoperability

Artificial intelligence in pneumonia imaging is experiencing transformative shifts driven by breakthroughs in data integration and algorithmic sophistication. Cloud-based platforms now enable real-time analysis of high-resolution CT scans, while federated learning models facilitate collaboration across institutions without compromising patient privacy. These developments have accelerated the transition from experimental applications to mainstream diagnostic tools, ushering in a new paradigm of precision radiology.

Concurrent enhancements in user interfaces are streamlining clinician workflows, reducing manual annotation burden and fostering rapid adoption in emergency and radiology departments. At the same time, regulatory frameworks are evolving to keep pace with technological advancements, offering clearer pathways for software as a medical device. This dynamic landscape underscores the importance of interoperability standards and evidence-based validation, ensuring that AI solutions deliver consistent performance and integrate effortlessly into electronic health records and PACS.

Assessing the Comprehensive Implications of 2025 United States Tariff Policies on the AI Medical Imaging Software Supply Chain and Innovation Trajectory

The implementation of new United States tariffs in 2025 has introduced significant considerations for the supply chain of AI medical imaging software. Components critical to high-performance computing, such as specialized GPUs and sensor modules, face elevated import duties, potentially increasing production costs and affecting pricing strategies for end users. As a result, manufacturers and software developers must reassess sourcing strategies and explore domestic partnerships to mitigate cost inflation.

Pricing pressures may cascade through distribution channels, compelling healthcare organizations to navigate tighter budgets and prioritize investments in value-driven solutions. To counter these challenges, industry stakeholders are evaluating alternative procurement models, including local manufacturing collaborations and modular software licensing. These proactive measures aim to preserve innovation momentum while ensuring that AI-enabled pneumonia imaging tools remain financially accessible and technologically cutting-edge.

Distilling Crucial Insights from Modality, End User, Integration, Deployment, and Application Segmentation to Inform Strategic AI Imaging Solutions

A nuanced understanding of segmentation reveals how distinct market segments drive the adoption and evolution of AI software in pneumonia imaging. Insights into modality preferences indicate that high-resolution CT remains a cornerstone for detailed lung visualization, while low-dose CT applications are gaining traction in routine screening. MRI and ultrasound play complementary roles, offering non-ionizing alternatives that enhance diagnostic confidence in specific patient cohorts.

End user segmentation highlights that hospitals continue to lead implementation efforts, particularly within emergency departments where rapid triage is critical, and radiology departments where advanced algorithmic interpretation adds value. Diagnostic imaging centers and clinics are following closely, seeking solutions that balance cost and performance. Integration trends underscore the importance of seamless connectivity with electronic health records, while cloud and local PACS solutions support diverse IT infrastructures.

Deployment preferences are split between on-premises setups and cloud environments, with hybrid, private, and public cloud models addressing varying security and scalability requirements. Application segmentation shows that detection workflows, encompassing initial screening and diagnostic confirmation, remain the primary focus, alongside emerging use cases in monitoring, triage support, and workflow automation that optimize operational efficiency.

Unraveling Regional Dynamics Across the Americas, Europe Middle East and Africa, and Asia Pacific to Drive AI Pneumonia Imaging Market Adoption

Regional dynamics exert a profound influence on the trajectory of AI-enabled pneumonia imaging. In the Americas, robust healthcare infrastructure and early regulatory guidance have fostered rapid uptake of advanced imaging tools. Collaborative networks among leading research institutions drive continuous refinement of AI algorithms, positioning the region as a hotbed for clinical validation studies and pilot deployments.

In Europe Middle East and Africa, diverse healthcare systems present both challenges and opportunities. Adoption is propelled by initiatives to enhance telemedicine capacity and address underserved populations. Regulatory harmonization efforts are underway to streamline approval processes, while public-private partnerships bolster investments in digital health innovations that can operate in constrained settings.

Asia Pacific demonstrates remarkable growth potential, fueled by expanding medical device manufacturing capabilities and large patient cohorts. Governments in the region are prioritizing digital transformation, integrating AI frameworks into national healthcare agendas. This environment, characterized by competitive cost structures and accelerating digitization, is catalyzing widespread implementation of AI-driven pneumonia imaging solutions.

Highlighting Pioneering Technology Leaders and Innovative Collaborations Shaping the Future of AI Powered Pneumonia Imaging Solutions Worldwide

Key players in the AI pneumonia imaging space are leveraging strategic collaborations and continuous R&D to solidify their market positions. Established medical technology corporations are integrating proprietary algorithms into existing imaging hardware, enhancing platform compatibility and clinician trust. These leaders are forging alliances with academic centers to access diverse clinical datasets and validate algorithm performance across demographic cohorts.

At the same time, agile startups are introducing niche solutions that address specific workflow bottlenecks, from automated triage sorting to longitudinal monitoring of treatment response. Partnerships between cloud service providers and software vendors are expanding deployment options, offering both scalable public cloud access and secure private cloud environments tailored to institutional policies. This competitive landscape underscores a shared focus on interoperability, regulatory compliance, and user-centric design, with each organization striving to deliver turnkey solutions that blend diagnostic accuracy with operational efficiency.

Practical Strategic Recommendations for Industry Leaders to Accelerate Adoption, Foster Innovation, and Enhance Outcomes in AI Pneumonia Imaging Deployment

Industry leaders should prioritize the development of interoperable architectures that integrate seamlessly with existing health IT ecosystems. By adopting open standards for data exchange and collaborating with EHR and PACS vendors, organizations can reduce implementation timelines and enhance clinician adoption. It is imperative to invest in real-world evidence generation, partnering with healthcare systems to conduct longitudinal studies that demonstrate the clinical and economic impact of AI-driven pneumonia imaging.

Leaders must also cultivate multi-stakeholder initiatives, engaging payers, clinicians, and regulatory bodies early in the product lifecycle to streamline market entry and reimbursement pathways. Emphasizing transparent algorithmic validation and explainable AI will foster stakeholder confidence, supporting broader acceptance in both acute care and ambulatory settings. Finally, establishing continuous education programs for radiologists and technologists will ensure that end users maximize the potential of advanced imaging analytics and maintain high standards of diagnostic quality.

Exploring Rigorous Research Methods Combining Quantitative and Qualitative Analysis to Ensure Reliability and Validity in AI Pneumonia Imaging Software Insights

This research integrates qualitative and quantitative methodologies to deliver a robust and comprehensive analysis of the AI pneumonia imaging landscape. Primary interviews with industry executives, clinical experts, and regulatory specialists provided firsthand insights into adoption challenges and success factors. Secondary research, including peer-reviewed literature, technical white papers, and public regulatory filings, was triangulated to validate emerging trends and technology roadmaps.

Data analysis employed rigorous statistical techniques, comparing performance metrics across imaging modalities and segmentation categories. Case studies highlighted real-world deployments, illustrating how different integration and deployment models influence clinical workflows. Patent analysis and competitive benchmarking offered an in-depth view of innovation pipelines, while detailed reviews of regulatory frameworks mapped approval pathways across key regions. This methodological approach ensures that findings are both reliable and actionable, supporting strategic decision-making for stakeholders across the value chain.

Concluding the Strategic Imperatives for Advancing AI Driven Medical Imaging in Pneumonia Care and Shaping Future Research and Development Priorities

The convergence of AI and medical imaging presents a pivotal opportunity to redefine pneumonia diagnosis and management. Strategic investments in technology development, combined with clear regulatory engagement, will catalyze the transition from pilot projects to routine clinical use. By aligning segmentation insights, regional trends, and tariff considerations, stakeholders can craft informed strategies that optimize product portfolios and market entry plans.

Looking ahead, the emphasis on interoperability, data privacy, and algorithmic transparency will shape the competitive landscape. As adoption accelerates in diverse healthcare settings, collaborative ecosystems will drive continuous improvement, enabling AI solutions to meet evolving clinical needs. This conclusion underscores the imperative for coordinated action among technology providers, healthcare institutions, and policymakers to realize the full potential of AI-enabled pneumonia imaging and improve patient outcomes globally.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Modality
    • Ct Scan
      • High Resolution CT
      • Low Dose CT
    • Mri
    • Ultrasound
    • X Ray
  • End User
    • Clinics
    • Diagnostic Imaging Centers
    • Hospitals
      • Emergency Department
      • Radiology Department
  • Integration
    • Ehr Integrated
    • Pacs Integrated
      • Cloud Pacs
      • Local Pacs
    • Standalone
  • Deployment
    • Cloud
      • Hybrid Cloud
      • Private Cloud
      • Public Cloud
    • On Premises
  • Application
    • Detection
      • Diagnostic Confirmation
      • Initial Screening
    • Monitoring
    • Triage
    • Workflow Automation
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Qure.ai Pvt Ltd
  • Lunit Inc
  • Zebra Medical Vision Ltd
  • Infervision Inc
  • Aidoc Medical Ltd

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. FDA clearance of deep learning chest X-ray analysis tools for pneumonia detection in emergency department triage processes
5.2. Integration of AI-powered pneumonia detection modules into cloud-based radiology platforms for remote diagnostics
5.3. Implementation of federated learning networks for cross-institutional pneumonia imaging model development and validation
5.4. Adoption of explainable AI frameworks to improve clinician trust in automated pneumonia diagnosis support tools
5.5. Collaboration between AI developers and EHR vendors for seamless pneumonia imaging data interoperability in clinical workflows
5.6. Development of multi-modal AI models combining chest CT images and patient vitals for enhanced pneumonia severity assessment
5.7. Cost-benefit analyses demonstrating reduced time-to-diagnosis and hospital stays with AI-driven pneumonia imaging solutions
5.8. Emergence of mobile radiography units equipped with AI algorithms to address pneumonia screening in low-resource settings
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI Medical Imaging Software for Pneumonia Market, by Modality
8.1. Introduction
8.2. Ct Scan
8.2.1. High Resolution CT
8.2.2. Low Dose CT
8.3. Mri
8.4. Ultrasound
8.5. X Ray
9. AI Medical Imaging Software for Pneumonia Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Imaging Centers
9.4. Hospitals
9.4.1. Emergency Department
9.4.2. Radiology Department
10. AI Medical Imaging Software for Pneumonia Market, by Integration
10.1. Introduction
10.2. Ehr Integrated
10.3. Pacs Integrated
10.3.1. Cloud Pacs
10.3.2. Local Pacs
10.4. Standalone
11. AI Medical Imaging Software for Pneumonia Market, by Deployment
11.1. Introduction
11.2. Cloud
11.2.1. Hybrid Cloud
11.2.2. Private Cloud
11.2.3. Public Cloud
11.3. On Premises
12. AI Medical Imaging Software for Pneumonia Market, by Application
12.1. Introduction
12.2. Detection
12.2.1. Diagnostic Confirmation
12.2.2. Initial Screening
12.3. Monitoring
12.4. Triage
12.5. Workflow Automation
13. Americas AI Medical Imaging Software for Pneumonia Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa AI Medical Imaging Software for Pneumonia Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific AI Medical Imaging Software for Pneumonia Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GE HealthCare Technologies Inc.
16.3.2. Siemens Healthineers AG
16.3.3. Koninklijke Philips N.V.
16.3.4. Canon Medical Systems Corporation
16.3.5. Fujifilm Holdings Corporation
16.3.6. Qure.ai Pvt Ltd
16.3.7. Lunit Inc
16.3.8. Zebra Medical Vision Ltd
16.3.9. Infervision Inc
16.3.10. Aidoc Medical Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET: RESEARCHAI
FIGURE 26. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET: RESEARCHSTATISTICS
FIGURE 27. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET: RESEARCHCONTACTS
FIGURE 28. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HIGH RESOLUTION CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HIGH RESOLUTION CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY LOW DOSE CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY LOW DOSE CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY X RAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY RADIOLOGY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY RADIOLOGY DEPARTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY EHR INTEGRATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY EHR INTEGRATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD PACS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD PACS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY LOCAL PACS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY LOCAL PACS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY STANDALONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY ON PREMISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DIAGNOSTIC CONFIRMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DIAGNOSTIC CONFIRMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INITIAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INITIAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY TRIAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY TRIAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY WORKFLOW AUTOMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY WORKFLOW AUTOMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 128. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 129. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 130. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 131. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 138. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 139. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 140. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 141. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 142. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 143. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 146. CANADA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 150. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 151. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 158. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 159. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 160. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 161. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 162. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 163. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 250. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 252. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 253. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 260. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 261. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 262. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2025-2030 (USD MILLION)
TABLE 263. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 264. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 265. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2018-2024 (USD MILLION)
TABLE 268. GERMANY AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DETECTION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 270. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 271. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2018-2024 (USD MILLION)
TABLE 272. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY CT SCAN, 2025-2030 (USD MILLION)
TABLE 273. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
TABLE 278. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
TABLE 279. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2018-2024 (USD MILLION)
TABLE 280. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY PACS INTEGRATED, 2025-2030 (USD MILLION)
TABLE 281. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEUMONIA MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
TABLE 282. FRANCE AI MEDICAL IMAGING SOFTWARE FOR PNEU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI Medical Imaging Software for Pneumonia market report include:
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Qure.ai Pvt Ltd
  • Lunit Inc
  • Zebra Medical Vision Ltd
  • Infervision Inc
  • Aidoc Medical Ltd